Global Glaucoma Surgical Devices Market Size By Type (Glaucoma Drainage Devices, Glaucoma Laser Systems), By Application (Consumers, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Glaucoma Surgical Devices Market was valued at USD 2.4 billion in 2023 and is projected to surpass USD 4.3 billion by 2031, growing at a CAGR of 7.5% during the forecast period from 2023 to 2031. The rising prevalence of glaucoma, a leading cause of irreversible blindness worldwide, is a significant factor driving market growth. Increasing awareness, improved access to eye care services, and advances in minimally invasive glaucoma surgery (MIGS) are propelling the demand for surgical interventions and specialized devices. With aging populations globally and increased screening programs, the market for glaucoma surgical devices is expected to expand steadily.

Drivers:

1. Rising Glaucoma Prevalence Globally:

An aging population and higher incidence of diabetes and hypertension—risk factors for glaucoma—are contributing to a rise in glaucoma cases, boosting demand for effective surgical treatments.

2. Technological Advancements in MIGS Devices:

Innovations in MIGS technologies offer safer, less invasive alternatives with quicker recovery times, thus attracting both ophthalmologists and patients.

3. Increasing Government and NGO Screening Programs:

Public health initiatives focused on early glaucoma detection, particularly in emerging economies, are promoting surgical intervention at earlier stages, thus fueling market demand.

Restraints:

1. High Costs of Advanced Devices and Procedures:

Premium surgical devices and associated operating costs may limit adoption in low-income regions, especially without insurance coverage or subsidies.

2. Limited Access to Specialized Eye Care in Rural Areas:

Although awareness is growing, many developing regions still lack trained ophthalmic surgeons and surgical infrastructure, restricting market penetration.

Opportunity:

1. Expansion into Emerging Markets with Growing Healthcare Infrastructure:

Regions such as Latin America, Southeast Asia, and parts of Africa present untapped opportunities due to rising healthcare investments and increasing awareness of glaucoma.

2. Rising Preference for Outpatient Surgical Procedures:

The shift towards outpatient and day surgeries for glaucoma interventions, driven by cost efficiency and reduced patient burden, offers growth prospects for device manufacturers.

Market by System Type Insights:

The Implant Devices segment held the largest market share in 2023, with rising adoption of stents and shunts due to their effectiveness in reducing intraocular pressure (IOP). Innovations such as micro-stent technologies are gaining traction due to their minimally invasive nature. The Laser Devices segment is also expected to witness significant growth, driven by increased use in selective laser trabeculoplasty (SLT) procedures.

Market by End-use Insights:

Hospitals and Eye Specialty Clinics dominated the market in 2023, accounting for over 60% of total revenue, as these institutions are primary providers of glaucoma surgeries. The Ambulatory Surgical Centers (ASCs) segment is projected to grow rapidly due to the rising number of outpatient glaucoma surgeries and cost-effective care models.

Market by Regional Insights:

North America led the global glaucoma surgical devices market in 2023, driven by high healthcare expenditure, early adoption of new technologies, and a strong presence of leading market players. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by a growing elderly population, rising healthcare investments, and increasing awareness in countries like India and China.

Competitive Scenario:

Key players in the Global Glaucoma Surgical Devices Market include Alcon Inc., Johnson & Johnson Vision, Glaukos Corporation, Santen Pharmaceutical Co., Ltd., Nova Eye Medical, Ellex Medical Lasers, New World Medical, and Ivantis Inc. These companies focus on R&D, geographic expansion, and strategic partnerships. Notable developments include:

2023: Glaukos Corporation launched the next-generation iStent Infinite System, designed for enhanced MIGS performance.

2024: Alcon received FDA approval for its advanced minimally invasive glaucoma implant, improving post-surgical IOP control.

2025: Santen and Verily Life Sciences announced a collaboration to develop smart diagnostic devices integrated with surgical tools for real-time IOP monitoring.

Scope of Work – Global Glaucoma Surgical Devices Market

Report Metric Details

Market Size (2023) USD 2.4 billion

Projected Market Size (2031) USD 4.3 billion

CAGR (2023–2031) 7.5%

Market Segments By System Type (Implant Devices, Laser Devices), End-use, Region

Growth Drivers Rising glaucoma prevalence, MIGS advancements, public health initiatives

Opportunities Emerging markets, shift to outpatient surgeries

Key Market Developments:

March 2023: Ivantis Inc. expanded distribution of its Hydrus Microstent in Latin America, increasing access to MIGS technologies.

July 2024: Nova Eye Medical introduced a new surgical system combining canaloplasty with IOP monitoring features.

January 2025: Johnson & Johnson Vision announced a strategic partnership with a teleophthalmology startup to integrate AI-assisted screening with surgical referral pathways.

FAQs:

1) What is the current market size of the Global Glaucoma Surgical Devices Market?

The market was valued at USD 2.4 billion in 2023.

2) What is the major growth driver of the Global Glaucoma Surgical Devices Market?

The major driver is the rising global prevalence of glaucoma, combined with advancements in minimally invasive surgical technologies.

3) Which is the largest region during the forecast period in the Global Glaucoma Surgical Devices Market?

North America is the largest region, with Asia-Pacific expected to grow at the fastest pace.

4) Which segment accounted for the largest market share in Global Glaucoma Surgical Devices Market?

The Implant Devices segment held the largest share in 2023.

5) Who are the key market players in the Global Glaucoma Surgical Devices Market?

Key players include Alcon Inc., Johnson & Johnson Vision, Glaukos Corporation, and Santen Pharmaceutical Co., Ltd.

Would you